• The two sides will also collaborate in the field of medical education and research as well as medical tourism. 
  • MoU in line with the DHA’s priority to provide high quality internationally recognised standards of accessible patient-centered care. 
  • Al Ketbi: DHA is keen to collaborate with esteemed medical and academic institutions. 

Dubai, United Arab Emirates:  In line with the aim of the Dubai Health Authority (DHA) to provide high quality internationally recognised standards of accessible patient-centered care, DHA has signed a MoU with Al Jalila Children's Specialty Hospital.

The MoU will help facilitate collaboration in the field of medical education and research. It will also help in exchange of expertise and will foster collaboration in specialised paediatric fields of medicine such as organ transplant.

The MoU was signed by His Excellency Awadh Al Ketbi, Director General of the Dubai Health Authority and Dr. Abdulla Ibrahim Al Khayat, Chief Executive Officer of Al Jalila Children's Specialty Hospital at the DHA Headquarters.

The MoU was signed in the presence of Dr. Alawi Alsheikh Ali, Deputy Director General of the DHA, Jamal Abdul Salam, CEO of Dubai Healthcare City Authority, Dr. Ramadan Alblooshi, Chief Regulatory Officer at Dubai Healthcare City Authority, Dr. Mohamed Al Awadhi, Chief Operating Officer at Al Jalila Children's Specialty Hospital and a number of senior DHA officials.

Al Ketbi highlighted that DHA is keen to collaborate with esteemed medical and educational institutions with an aim to provide high-quality patient centered care.

He added that fostering medical education and research, collaborating and sharing expertise particularly in rare medical fields and knowledge transfer are key areas to help further develop and bolster Dubai’s health sector.

His Excellency pointed out that DHA’s Latifa Hospital for Women and Children and Al Jalila Children’s Specialty Hospital are recognized not only in the country but also regionally for their expertise and this MoU will further open up avenues for collaboration with an aim to provide the highest quality of specialized pediatric care.

-Ends-

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.